TFGT
RPRX icon

TS Financial Group (TSFG)’s Royalty Pharma RPRX Stock Holding History

TS Financial Group (TSFG)’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-351
Closed -$14K – 999
2021
Q4 		$14K Sell
351
-1,569
-82% -$61K ﹤0.01% 507
2021
Q3 		$69K Buy
1,920
+90
+5% +$3.5K 0.03% 277
2021
Q2 		$75K Buy
+1,830
New +$77.8K 0.03% 259

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SGA
Siguler Guff Advisers New York $56.1M AUM 46.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

TS Financial Group (TSFG)'s RPRX Position: Q1 2022 in Review

TS Financial Group (TSFG) sold out of Royalty Pharma (RPRX) in Q1 2022, closing a stake of 351 shares — an estimated $14K sold.

TS Financial Group (TSFG) first reported a position in RPRX in Q2 2021 and held it in 3 quarters. The position peaked at $75K in Q2 2021. 279 funds tracked by Wall St. Rank hold RPRX as of Q1 2022.

  • TS Financial Group (TSFG) reported no remaining Royalty Pharma position as of Q1 2022 after selling out during the quarter.
  • TS Financial Group (TSFG) sold 351 Royalty Pharma shares in Q1 2022, an estimated $14K.
  • TS Financial Group (TSFG) first reported a position in Royalty Pharma in Q2 2021 and held it in 3 quarters.
  • TS Financial Group (TSFG)'s Royalty Pharma position peaked at $75K in Q2 2021.
  • 279 funds tracked by Wall St. Rank held Royalty Pharma as of Q1 2022.

Based on TS Financial Group (TSFG)'s 13F filing for Q1 2022, filed 25 Apr 2022.